Author:
Foster C S, ,Dodson A R,Ambroisine L,Fisher G,Møller H,Clark J,Attard G,De-Bono J,Scardino P,Reuter V E,Cooper C S,Berney D M,Cuzick J
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. Adams DJ, Hajj H, Edwards DP, Bjercke RJ, McGuire WL (1983) Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies. Cancer Res 43: 4297–4301
2. Adolfsson J, Steineck G, Hedlund P-O (1997) Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska series. Urology 50: 722–726
3. Albertsen P, Hanley JA, Fine J (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293: 2095–2101
4. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J (1995) Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274: 626–631
5. Attard G, Clark J, Ambroisine L, Fisher G, Kovacs G, Flohr P, Berney D, Foster CS, Fletcher A, Gerald WL, Moller H, Reuter V, De Bono JS, Scardino P, Cuzick J, Cooper CS (2008a) Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 27: 253–263
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献